Burning Rock Biotech Limited
BNR
$3.06
-$0.3499-10.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.44% | -2.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.44% | -2.51% | |||
| Cost of Revenue | -3.59% | -1.02% | |||
| Gross Profit | 7.72% | -3.11% | |||
| SG&A Expenses | -15.02% | 2.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.16% | 2.84% | |||
| Operating Income | 67.92% | -20.69% | |||
| Income Before Tax | 82.72% | -112.73% | |||
| Income Tax Expenses | -95.83% | 2,528.83% | |||
| Earnings from Continuing Operations | 83.58% | -126.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 83.58% | -126.33% | |||
| EBIT | 67.92% | -20.69% | |||
| EBITDA | 93.21% | -490.07% | |||
| EPS Basic | 84.22% | -126.05% | |||
| Normalized Basic EPS | 69.13% | -14.24% | |||
| EPS Diluted | 84.22% | -126.05% | |||
| Normalized Diluted EPS | 69.13% | -14.24% | |||
| Average Basic Shares Outstanding | 4.12% | 0.13% | |||
| Average Diluted Shares Outstanding | 4.11% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||